David Bouchey Stock Analyst Profile - Aegis Capital Research Coverage - Stocknear

David Bouchey

Stock Analyst at Aegis Capital

(1.5)
# 3409
Out of 5,506 analysts
7
Total ratings
Success rate
Average return

5 Stocks

Name Action PT Current % Upside Ratings Updated
SBFM Sunshine Biopharma
Reiterates: Buy
15 15
1.53 880.39% 2 Dec 5, 2024
STSS Sharps Technology
Initiates Coverage On: Buy
105600
6.75 1564344.44% 1 May 9, 2023
ATXI Avenue Therapeutics
Initiates Coverage On: Buy
2400
0.69 347726.09% 1 Apr 3, 2023
IINN Inspira Technologies...
Maintains: Buy
10 13
1.2 983.33% 1 Jan 25, 2023
RMTI Rockwell Medical
Downgrades: Outperform
121
1.22 9818.03% 2 Oct 19, 2018